Skin cancer is the most common cancer in the U.S., with risks influenced by factors like sun exposure, skin type, and income.

Philip Bergman, DVM, MS, PhD, DACVIM (Oncology), kicked off the 2025 Fetch Charlotte conference with his keynote address on ...

In September of last year, Ohio mum Michelle Tagliamonte looked down at her hands and noticed something odd about one of her ...

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called ...

Mohs micrographic surgery tops conventional excision for hand and foot melanomas by reducing rates of reconstruction with ...

Mellencamp’s cancer journey began in March 2022 when she took to Instagram to reveal that she’d had a suspicious mole removed ...

Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...

Teddi Mellencamp talked in-depth about her cancer journey after reuniting with Tamra Judge on their podcast. Hear the new details.

Professor Richard Scolyer tells ABC Radio Sydney that a clinical trial is the next step for his melanoma research, but will ...

Less than a month after sharing that she had multiple brain tumors resulting from her past battle with melanoma, Teddi ...

Although the tilsotolimod plus ipilimumab treatment did not meet its co-primary endpoint, these results are a valuable addition to the literature with respect to second-line treatment options in this ...

Metastatic melanoma is the most aggressive form of skin cancer. In an effort to achieve targeted therapy for metastatic melanoma, researchers recently developed a new radioactive drug that emits alpha ...